Molecular Diagnostics Specialist - Oregon Territory
MDxHealth
Summary
The Molecular Diagnostic Specialist (MDS) will be responsible for the Sales and Marketing of mdxhealth's oncology product line within a defined territory. Initially, the MDS will be responsible for calling on Surgeons, Urologists, and Pathologists to create demand for mdxhealth's products. The MDS will be responsible for driving new oncology business, maintaining customer relationships and meeting and exceeding sales targets established by the management team. Responsible for compliance to all applicable regulations including but not limited to the Food and Drug Administration, ISO and State and Federal requirements.
Job description
- Oregon Territory. Will cover Oregon, South Idaho and Montana
- Ideal location for a candidate is in the Portland, OR area. Must be close to a major airport and must be able to travel.
- Experience in medical sales as a top performer.
- Bachelor's Degree preferred with 3 to 5 years related experience.
- Well organized with the ability to successfully manage the territory.
- Excellent written and verbal communication.
- Technical ability to teach others scientific data pertaining to mdxhealth products.
- Team player with positive attitude
Requirements
- Experience in medical sales as a top performer
- Bachelor's Degree preferred
- 3 to 5 years related experience
- Well organized with the ability to successfully manage the territory
- Excellent written and verbal communication
- Technical ability to teach others scientific data pertaining to mdxhealth products
- Team player with positive attitude
- Must be close to a major airport and able to travel
Benefits
- Medical, Dental & Vision
- Life Insurance
- 401(k) Matching
- Employee Discounts
Company overview
MDxHealth is a commercial-stage molecular diagnostics company that specializes in the development and commercialization of epigenetic and other molecular tests for urologic cancers, with a primary focus on prostate cancer. The company's flagship product is the SelectMDx test, a non-invasive urine-based molecular test that helps physicians determine the need for a prostate biopsy in men with elevated PSA levels. MDxHealth utilizes advanced molecular technologies including DNA methylation analysis and gene expression profiling to provide more accurate risk assessment and personalized treatment guidance. The company's diagnostic solutions aim to improve patient outcomes by enabling more precise diagnosis and reducing unnecessary invasive procedures. With operations in both the United States and Europe, MDxHealth is positioned as a leader in the field of urologic molecular diagnostics, offering innovative testing solutions that address critical clinical decision points in cancer management.